foscarnet has been researched along with Hepatitis B in 12 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Foscarnet has been shown to inhibit the proliferation of human T and B lymphocytes in vitro." | 1.28 | Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response? ( Hansson, BG; Nordenfelt, E; Riesbeck, K; Weiland, O, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheraz, M | 1 |
| Cheng, J | 1 |
| Tang, L | 1 |
| Chang, J | 1 |
| Guo, JT | 1 |
| Brown, TJ | 1 |
| McCrary, M | 1 |
| Tyring, SK | 1 |
| Lin, HJ | 1 |
| Wu, PC | 1 |
| Lai, CL | 1 |
| Chak, W | 1 |
| Morales, JM | 1 |
| Muñoz, MA | 1 |
| Fernández Zataraín, G | 1 |
| García Cantón, C | 1 |
| García Rubiales, MA | 1 |
| Andrés, A | 1 |
| Aguado, JM | 1 |
| Gonzalez Pinto, I | 1 |
| Singh, N | 1 |
| Gayowski, T | 1 |
| Antinori, S | 1 |
| Esposito, R | 1 |
| d'Arminio Monforte, A | 1 |
| Moroni, M | 1 |
| Hansson, BG | 2 |
| Riesbeck, K | 1 |
| Nordenfelt, E | 2 |
| Weiland, O | 2 |
| Bain, VG | 1 |
| Daniels, HM | 1 |
| Chanas, A | 1 |
| Alexander, GJ | 1 |
| Williams, R | 1 |
| Price, JS | 1 |
| France, AJ | 1 |
| Moaven, LD | 1 |
| Welsby, PD | 1 |
| Sherker, AH | 1 |
| Hirota, K | 1 |
| Omata, M | 1 |
| Okuda, K | 1 |
| Tsiquaye, KN | 1 |
| Collins, P | 1 |
| Zuckerman, AJ | 1 |
| Hedin, G | 1 |
| Ljunggren, K | 1 |
| Strömberg, A | 1 |
| Oberg, B | 1 |
1 review available for foscarnet and Hepatitis B
| Article | Year |
|---|---|
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Fos | 2002 |
11 other studies available for foscarnet and Hepatitis B
| Article | Year |
|---|---|
Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Topics: Antiviral Agents; DNA Topoisomerases; DNA, Circular; DNA, Viral; Foscarnet; Genome, Viral; Hep G2 Ce | 2019 |
Micromethod for phosphonoformate inhibition assay of hepatitis B viral DNA polymerase.
Topics: Deoxycytosine Nucleotides; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B; Hepatitis B virus; H | 1984 |
Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
Topics: Acute Kidney Injury; Adult; Antiviral Agents; Cyclosporine; Cytomegalovirus Infections; Drug Interac | 1995 |
Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation.
Topics: Drug Therapy, Combination; Foscarnet; Ganciclovir; Hepatitis B; Humans; Liver Transplantation; Male; | 1995 |
Foscarnet treatment of chronic hepatitis B in an HIV-positive patient.
Topics: Adult; Chronic Disease; Foscarnet; Hepatitis B; HIV Seropositivity; Humans; Male | 1993 |
Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
Topics: Antiviral Agents; B-Lymphocytes; Cell Line; Cells, Cultured; DNA; Foscarnet; Hepatitis B; Hepatitis | 1991 |
Foscarnet therapy in chronic hepatitis B virus E antigen carriers.
Topics: Adult; Antiviral Agents; Carrier State; DNA, Viral; Foscarnet; Hepatitis B; Hepatitis B Surface Anti | 1989 |
Foscarnet in fulminant hepatitis B.
Topics: Adolescent; Antiviral Agents; Foscarnet; Hepatic Encephalopathy; Hepatitis B; Humans; Organophosphor | 1986 |
Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Topics: Animals; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Ducks; Enterovirus Infectio | 1986 |
Screening of antiviral drugs for treatment of hepatitis B.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Ducks; Foscarnet; Hepatitis B; H | 1986 |
Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Hepatitis B; Hepatitis D; Hum | 1987 |